We are live on ! Find out more
AGP

Aspire Growth Partners Portfolio holdings

AUM $172M
1-Year Est. Return 33.61%
This Fund
S&P 500
This Quarter Est. Return
+19.21%
1 Year Est. Return
+33.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$172M
AUM Growth
+$26.4M
Cap. Flow
+$7.14M
Cap. Flow %
4.15%
Top 10 Hldgs %
49.5%
Holding
135
New
14
Increased
66
Reduced
40
Closed
7

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$542K
2
STE icon
Steris
STE
+$464K
3
CMCSA icon
Comcast
CMCSA
+$251K
4
MPC icon
Marathon Petroleum
MPC
+$245K
5
CVX icon
Chevron
CVX
+$244K

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.33%
2 Technology 17.71%
3 Industrials 5.84%
4 Financials 5.04%
5 Communication Services 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRWD icon
126
CrowdStrike
CRWD
$215B
$202K 0.12%
+1,060
New +$151K
MRVL icon
127
Marvell Technology
MRVL
$203B
$201K 0.12%
+674
New +$135K
JPC icon
128
Nuveen Preferred & Income Opportunities Fund
JPC
$2.75B
$96.3K 0.06%
12,226
-530
-4% -$4.17K
BBY icon
129
Best Buy
BBY
$18.8B
-3,454
Closed -$222K
CMCSA icon
130
Comcast
CMCSA
$93.4B
-8,758
Closed -$251K
CVX icon
131
Chevron
CVX
$412B
-1,178
Closed -$244K
HCA icon
132
HCA Healthcare
HCA
$87B
-464
Closed -$219K
IQV icon
133
IQVIA
IQV
$42.7B
-1,211
Closed -$207K
STE icon
134
Steris
STE
$21.3B
-2,098
Closed -$464K
ZTS icon
135
Zoetis
ZTS
$30.4B
-4,583
Closed -$542K

Similar funds

Aspire Growth Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Aspire Growth Partners held 135 positions worth $172M, up 18% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Aspire Growth Partners deployed $7.14M of net new capital in Q2 2026, opening 14 new positions and adding to 66 existing holdings. Its largest new stake was Edwards Lifesciences: 3,963 shares worth $358K.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 49% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $245K trimmed.

  • Aspire Growth Partners's largest Q2 2026 buy was Edwards Lifesciences: 3,963 shares worth $358K.
  • Aspire Growth Partners added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.23M increase.
  • Aspire Growth Partners's biggest Q2 2026 reduction was Marathon Petroleum, cutting an estimated $245K.
  • Aspire Growth Partners fully exited Zoetis in Q2 2026, selling an estimated $542K.
  • Aspire Growth Partners's ten largest holdings make up 50% of its $172M portfolio in Q2 2026.
  • Aspire Growth Partners opened 14 new positions and closed 7 in Q2 2026.
  • Aspire Growth Partners's portfolio value rose 18% quarter-over-quarter to $172M.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.